Feb 04, 2022 / 12:30PM GMT
Eva Schaefer-Jansen - Sanofi - IR Officer
Good morning, good afternoon and good evening to everyone. Thank you for joining us to review Sanofi's 2021 fourth quarter and full year results, followed by a Q&A session. As usual, you can find the slides to this earnings call on the Investors page of our website at sanofi.com.
Moving to Slide 3, I would like to remind you that information presented in this call contain forward-looking statements that involve known and unknown risks, uncertainties and other factors that may cause actual results to differ materially. I refer you to our Form 20-F document on file with the SEC and also our Document d'Enregistrement Universel for a description of these risk factors.
With that, please advance to Slide 4. Our speakers on the call today are Paul Hudson, Chief Executive Officer; the Global Business Unit Heads, Bill Sibold, Thomas Triomphe, Olivier Charmeil; and Julie Van Ongevalle; and Jean-Baptiste de Chatillon, Chief Financial Officer.
For the Q&A, you have 2 options to participate. Option 1, click the raise hand
Q4 2021 Sanofi SA Earnings Call Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot